Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Catalyst Pharmaceuticals Inc shares valued at $805,543 were purchased by INGENITO GARY on Nov 20 ’24. At $21.20 per share, INGENITO GARY acquired 38,000 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MCENANY PATRICK J purchased 72,500 shares, netting a total of over 1,543,555 in proceeds.
Before that, MCENANY PATRICK J had added 98,345 shares to its account. In a trade valued at $2,083,726, the Director bought Catalyst Pharmaceuticals Inc shares for $21.19 each.
As published in their initiating research note from Stephens on November 18, 2024, Catalyst Pharmaceuticals Inc [CPRX] has been an Overweight and the price target has been revised to $35. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of March 07, 2024, BofA Securities has initiated its “Buy” rating for CPRX. Earlier on December 21, 2023, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for CPRX stock.
Analyzing CPRX Stock Performance
During the last five days, there has been a drop of approximately -7.24%. Over the course of the year, Catalyst Pharmaceuticals Inc shares have jumped approximately 25.82%. Shares of the company reached a 52-week high of $24.27 on 11/08/24 and a 52-week low of $13.12 on 02/08/24. A 50-day SMA is recorded $21.09, while a 200-day SMA reached $17.53. Nevertheless, trading volume fell to 0.95 million shares from 1.12 million shares the previous day.
Support And Resistance Levels for Catalyst Pharmaceuticals Inc (CPRX)
According to the 24-hour chart, there is a support level at 20.92, which, if violated, would cause prices to drop to 20.70. In the upper region, resistance lies at 21.50. The next price resistance is at 21.86. RSI (Relative Strength Index) is 45.53 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.05, which suggests the price will decrease in the coming days. Percent R is at 81.46%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
